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Human meniscus is a fibrocartilaginous structure that is crucial for an adequate performance 
of the human knee joint. Degeneration of the meniscus is often followed by partial or total 
meniscectomy, which enhances the risk of developing knee osteoarthritis. The lack of a 
satisfactory treatment for this condition has triggered a major interest in drug delivery and 
tissue engineering strategies intended to restore a bioactive and fully functional meniscal 
tissue. The aim of this review is to critically discuss the most relevant studies on spatio-
temporal drug delivery and tissue engineering, aiming for a multi-zonal meniscal 
reconstruction. Indeed, the development of meniscal tissue implants should involve a 
provision for adequate active molecules and scaffold features that take into account the 
anisotropic ultrastructure of human meniscus. This zonal differentiation is reflected in the 
meniscus biochemical composition, collagen fiber arrangement and cell distribution. In this 
sense, it is expected that a proper combination of advanced drug delivery and zonal tissue 
engineering strategies will play a key-role in the future trends in meniscus regeneration.             
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Meniscus degeneration is one of the main causes of knee pain, inflammation and reduced 
mobility. Currently used suturing procedures and meniscectomy are far from being ideal 
solutions to the loss of meniscal function. Therefore, drug delivery (DD) and tissue engineering 
(TE) strategies are currently under investigation. DD systems aim at an in-situ controlled 
release of growth factors, whereas TE strategies aim at mimicking the anisotropy of native 
meniscus. The goal of this review is to discuss these two main approaches, as well as 
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The human knee meniscus is a C-shaped anatomical structure made of fibrocartilage. It 
absorbs the shock generated during motion and distributes the compressive load derived from 
the femur to the underlying hyaline cartilage and bone. The meniscus also contributes to joint 
stability, lubrication and proprioception, i.e. the perception of the body position and 
movement1. Due to its limited vascularization and poor cellularity, the self-healing capacity of 
the meniscus following an acute injury or a chronic degenerative process is minimal. 
Therefore, surgical intervention using sutures or (partial or total) meniscal removal is often 
needed. Although these procedures are currently part of the clinical routine, the limited 
success rate of suturing and the increased risk of osteoarthritis upon meniscectomy, have 
triggered a growing interest in the tissue engineering (TE) field. A typical TE approach 
involves the use of (i) a biomaterial, capable to provide a transitory mechanical support and a 
cell-friendly three-dimensional (3D) environment, (ii) cells (seeded or recruited from the 
surrounding healthy tissue), and/or (iii) active factors that can augment the cell-mediated 
tissue repair. 
An emerging concept in meniscal TE is the bio-mimicry of meniscal anisotropy. Indeed 
in human meniscus, the extra-cellular matrix (ECM) composition, the cells distribution and the 
collagen fiber arrangement vary in a spatially-relevant manner, being these architectural 
features crucial for the meniscus function2. The three main strategies currently exploited to 
promote anisotropic and functional meniscal regeneration are: (i) controlled delivery of growth 
factors via drug delivery (DD) systems, (ii) mimicry of meniscal ultrastructural features via 
modern TE technologies, and (iii) a combination of the previous two. The aim of this review is 
to provide a full and critical picture on this topic. This, to the best of our knowledge, has not 
been done before.        
The active factors used in meniscus regeneration are mainly growth factors (GFs) 
that are meant to promote tissue repair by different mechanisms, e.g. by stimulating cell 
migration, proliferation and tissue ingrowth. However, one of the main challenges for the 
clinical application of GFs is their rapid clearance after in vivo injection. To circumvent this 
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limitation, long-lasting controlled DD strategies are being investigated. In this context, 
research has focused on the in-situ controlled delivery of GFs and polynucleotides. The first 
part of this review presents the approaches that have been reported for the controlled delivery 
of GFs. Other approaches based on the use of polynucleotides have already been described 
in recent reviews3-5.  
The second part of this review focuses on modern TE technologies that allow a 
spatially-controlled scaffold architecture and distribution of different cell types. These TE 
strategies involve the use of (i) advanced manufacturing technologies (3D printing and 
electrospinning) for the fabrication of zonally-variant architectures, (ii) post-fabrication zone-
dependent mechanical stimulation, able to mimic the complex mechanics of the in vivo 
osteoarticular environment, and (iii) spatially-selective seeding of different cell types in the 
scaffold, inspired by the cellular variation of the different meniscal zones.  
The fabrication of scaffolds that resemble zonal tissue variations is a recent trend in 
the field of meniscus TE, and the majority of the reported strategies lack a biological 
augmentation via GF delivery systems. Notwithstanding, a new generation of scaffolds is 
starting to combine biological augmentation via GF delivery systems with zonal TE 
approaches. In these scaffolds, discussed in the third part of this review, the DD system is 
part of a TE construct that attempts to recapitulate the native tissue architecture. In this 
context, modern TE technologies may allow a spatially-controlled distribution of DD systems 
within a scaffold displaying a zonally-variant architecture. We envisage that such approaches 
have a much higher potential to reconstruct a fully functional, anisotropic meniscus and will 
lead to a real breakthrough as the field evolves. 
 
2. Human knee meniscus 
2.1. Biochemistry and composition 
As stated above, human meniscus has an anisotropic structure, which presents zonal 
variations in terms of vascularization, cell type distribution, ECM composition and collagen 
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fiber arrangement (Figure 1). Three main zones have been identified, i.e. an innervated and 
vascularized outer region (also called red region), a non-innervated and avascular inner region 
(white region) and an intermediate region (red-white region).  
The meniscal ECM is composed of water (72%), collagen (22%), glycoproteins (3.5%), 
and a low percentage of proteoglycans (0.5%), although their content may vary based on the 
age and pathological conditions1, 2. As depicted in figure 1, collagen fibers have a zone-
dependent organization, crucial for the load transmission, which consists of a circumferential 
fiber arrangement more pronounced in the deeper layers and a radial assembly more 
pronounced in the superficial ones1. Collagen type I is the most abundant type of collagen in 
the outer region. In contrast, in the inner region, both collagen type I (typical collagen of scar 
tissue, ligaments and tendons) and type II (typical collagen of hyaline cartilage) are present in 
relatively high percentages (40 and 60%, respectively)1. Regarding the cell types, elongated 
fibroblast-like cells are present in the outer zone, whereas rounded chondrocyte-like cells, 
referred to as fibrochondrocytes, are embedded in the ECM of the inner zone. In the superficial 
layers, the presence of progenitor cells with a possible role during healing processes has been 
reported2.  
Given that the human temporomandibular joint disk (TMJD) and the anulus fibrosus of 
the intervertebral disk (IVD) are also fibrocartilaginous structures, we have included in this 
review the relevant studies based on DD strategies for TMJD and IVD tissue engineering that 
could, potentially, be applied also to meniscus regeneration. More details about the anatomy, 
biochemistry and functions of meniscus, TMJD and IVD, can be found in previous articles1, 2, 
6-8. 
 
2.2. Pathology and treatments 
Meniscal tissue degeneration typically occurs after an acute injury due to excessive 
axial and rotational load applied on the knee joint (traumatic or acute tears), or upon repetitive 
motion cycles during normal physical activity (degenerative tears)1, 9. The self-healing capacity 
of damaged meniscus is very limited, due to the scarce cell population and the low degree of 
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vascularization. Moreover, cell migration to the damaged tissue, which is an essential step for 
tissue healing, may be hindered by the stiffness and the high density of the meniscal tissue10.  
The treatment of the meniscal tears involves surgical suturing, and partial or total 
meniscectomy11, 12. Unfortunately, it has been estimated that 25% of the surgical interventions 
leads to an incomplete healing and 15% fails completely11. For lesions that cannot be repaired 
by suturing, such as complex degenerative tears, the treatment is based on partial or total 
meniscectomy.  
Nowadays, after decades performing meniscectomies, clinicians have become aware 
of the risk of post-meniscectomy osteoarthritic changes and reduced physical capability of the 
knee joint. Although these side effects depend on the general physio-pathological condition of 
the joint11, the current trend is toward minimizing the use of meniscectomy. DD and TE 
approaches may enable tissue regeneration of meniscal tears and may offer a potential 
treatment even after a partial or total meniscectomy, as discussed in the following sections. 
 
3. In situ delivery of growth factors for meniscus regeneration 
3.1. Growth factors for meniscus regeneration 
The active factors used in meniscus regeneration, for the re-establishment of a healthy and 
functional tissue after an acute or chronic degenerative process, are mainly GFs (i.e. proteins 
or their encoding polynucleotides). GFs are intended to promote meniscus regeneration by: 
(i) stimulating cell migration, especially needed for acellular scaffolds to recruit endogenous 
cells towards the defect area3, 13; (ii) promoting cell proliferation and chondrogenic 
differentiation3, 13, 14, (iii) activating anabolic pathways involved in meniscal ECM synthesis3, 
(iv) supporting angiogenesis15, and/or (v) stimulating a controlled tissue degradation to 
enhance cell penetration10.     
Of all the GFs, the transforming growth factor-β (TGF-β) superfamily (particularly TFG-
β1, TFG-β3, bone morphogenic protein-2 (BMP-2) and bone morphogenic protein-7 (BMP-
7)), the basic fibroblast growth factor (bFGF), and the insulin-like growth factor-1 (IGF-1) are 
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the ones that have been most thoroughly investigated for meniscal regeneration. For an 
extensive reading about the GFs employed in meniscal TE we refer to a recent review on the 
topic14.  
 Considering the heterogeneous structure of the meniscus and the different cell types 
involved in its formation, achieving a successful meniscal regeneration poses a big challenge, 
that may require the delivery of multiple GFs with different release kinetics. In fact, examples 
of synergistic effects between GFs, such as bFGF and TGF-β3; IGF-1 and TGF-β1; 
connective tissue growth factor (CTGF) and TGF-β3 have been reported14, and the 
exploitation of these synergies seems to be the direction this field will go as it evolves.  
3.2. Drug delivery systems 
Given the limited stability of the GFs, their application in an in vivo setting for meniscus 
regeneration would require multiple knee injections, a process whose translation into the 
clinical practice is far from ideal. To overcome this, DD systems have been investigated for 
the in-situ controlled release of GFs.  
When developing a novel DD system, commonly encountered challenges involve 
loading efficiency, adequate release kinetics and maintenance of the functionality of the 
cargo during the release time frame16-18. The latter aspect is of great importance especially 
for proteins, such as GFs, that can lose their activity under certain environmental conditions 
(pH, temperature, radiations, mechanical stress, organic solvents, etc.)19-21. Therefore, in the 
case of protein-loaded delivery systems, mild fabrication techniques and post-fabrication 
protein loading are often preferred22, 23.   
Another challenge that arise when developing DD systems for TE applications is to 
adapt the prolonged drug release profile to the slow process of neo-tissue formation, 
maturation and remodeling; a process that usually takes from weeks to months. In the case of 
certain biomaterials, the release kinetics of GFs can be controlled by adjusting material 
properties (e.g. particle size and lactide/glycolide ratio for poly-(lactic-co-glycolic acid)  (PLGA) 
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particles)24, 25. Alternatively, the payload can be covalently bound to the biomaterial to achieve 
a prolonged release22.  
 An emerging strategy in DD for TE is the spatio-temporal release of active molecules, 
which enables to precisely control the location and the time-frame of the drug release26. Due 
to the anisotropic structure of the meniscus, a region-dependent release of GFs could be 
crucial to accomplish the zonal tissue variation present in the native meniscus. Spatially-
controlled positioning of active factors can be achieved using 3D building technologies, such 
as 3D printing (discussed in section 5.1). Moreover, the temporal control over the release of 
one or more factors is crucial as synergistic effects can be obtained by a dual or multiple 
release of GFs27.  
 The following sections describe GF delivery strategies that attempt to heal mainly 
meniscal tears and other small fibrocartilaginous defects. Studies aiming at the regeneration 
of meniscus, TMJD and IVD, grouped according to the nature of the DD system are discussed 
below.  
 
3.2.1. Scaffolds as DD systems 
Scaffolds in TE can be defined as 3D porous structures capable of harboring living cells and 
promoting new tissue formation. For this purpose, scaffolds must fulfill certain requirements in 
terms of mechanical and bioactive properties. Often, scaffolds with adequate mechanical 
properties do not represent an ideal milieu for cell proliferation and differentiation, whereas 
those showing a cell-friendly microenvironment may not withstand the high load the meniscus 
undergoes in vivo28. Finding an adequate balance between these two requirements has been 
one of the biggest challenges for researchers in the field. Besides, bio-functionalization of 
scaffolds via GF incorporation appears to be a promising strategy to modulate tissue healing 
and regeneration. Among the different scaffolds that have been investigated in TE for 
fibrocartilage regeneration29, only those dealing with GF delivery are discussed herein. As 
described in the following sections, GF-loaded scaffolds have been developed by 
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incorporating the GF directly in the scaffold matrix or by engineering the GF in a multi-
component delivery system (i.e. microparticle-loaded scaffolds).   
 
3.2.1.1. Scaffolds based on extracellular matrix (ECM) components 
In an attempt to mimic the natural microenvironment of meniscal tissue, researchers have 
employed different macromolecules present in the ECM, such as collagen, hyaluronan, and 
fibrin, to develop scaffolds with biomimetic properties. These biomaterials form 3D hydrogel 
networks that are particularly suitable to carry GFs and to support cellular growth and 
proliferation. However, due to their poor mechanical properties, the use of these hydrogels as 
carriers for GFs has been restricted to the regeneration of small meniscal and 




Collagen, the most abundant protein in the ECM, has cell-binding sites that makes it an 
interesting material for use in the fabrication of scaffolds30. In fact, a meniscus scaffold based 
on collagen, namely Collagen Meniscus Implant (CMI®), is available on the market since 
2016. In order to improve the capacity to attract and differentiate cells, collagen scaffolds have 
been loaded with GFs for the treatment of fibrocartilage defects (Table 1). For example, Suzuki 
et al. tested the effect of BMP-2-loaded collagen type I scaffolds in a leporine TMJ injury model 
and observed a dose-dependent tissue healing31. However, scaffolds prepared only with 
collagen tend to show poor mechanical properties, for this reason this material is usually used 




Gelatin, obtained by the basic or acidic hydrolysis of collagen, also possesses cell-binding 
sites and it is currently investigated as a natural ECM-mimicking building block32-34. In general, 
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gelatin-based biomaterials can be made from gelatin of different isoelectric points, which can 
load cationic or anionic GFs via electrostatic interactions30, 35.  
 Gelatin has also the capacity to form thermosensitive hydrogels30, however, these 
hydrogels have to be crosslinked in order to improve their mechanical properties. For GF 
delivery, gelatin hydrogels have been crosslinked mainly via the chemical reaction of 
methacrylated gelatin (gelMA) in the presence of UV light and a photo-initiator36, 37, or via 
glutaraldehyde38, 39 (Table 1). For example, TGF-β3-loaded hydrogels based on gelMA 
showed a significant chondrogenic differentiation of adipose-derived stem cells during 21 
days. About 80% of the GF was released during this period36. Glutaraldehyde-crosslinked 
gelatin hydrogels have also been loaded with single GFs, such as FGF-239, or with GFs 
cocktails, such as platelet-rich plasma (PRP)38, an endogenous cocktail of GFs and platelets 
widely studied for musculoskeletal tissue regeneration. In both cases, positive outcomes were 
reported in terms of tissue repair in rabbits38, 39. In the studies describing glutaraldehyde-
crosslinked gelatin matrices, anionic gelatin (pI=5.0) was used, and loading of the cationic 
GFs was performed onto the pre-formed matrices. This post-fabrication loading technique 
avoided GF deactivation and chemical immobilization35.  
Only one of the studies dealing with gelatin-based hydrogels described, reports the 
release kinetic analysis of the loaded factor36. All other studies assumed a sustained release 
of the loaded factor, an assumption based on the results previously reported that indicated a 
degradation-based release mechanism35. In our opinion, although the in vitro/in vivo 
correlation is far from ideal, the in vitro release studies should be a must when using GFs, 
since their kinetics are crucial for a successful outcome of the biomolecule.  
In general, gelatin scaffolds seem to be preferred to collagen scaffolds in meniscal TE, 






Fibrin is a protein involved in blood clotting that is being currently investigated for biomedical 
applications40, 41, meniscus regeneration among others (Table 1). Fibrin is prepared from 
fibrinogen and thrombin, and it has the advantages of being biodegradable and of having both 
a rapid in situ gelation and the capacity to stimulate the endogenous healing response42. 
Moreover, because of its GFs selective binding, it is considered an appealing biomaterial for 
DD in TE. For example, He et al. demonstrated that CTGF-loaded fibrin hydrogel supported 
the tissue repair of the avascular meniscus in rabbits43. The structural properties of the fibrin 
systems can be tuned by changing, for example, the concentration of its precursors, which will 
also affect the release kinetics of the entrapped GFs42. Nevertheless, the main drawback of 
using fibrin is its poor mechanical stability. To overcome this limitation, platelet-rich fibrin (PRF) 
can be used. Unlike fibrin clots, PRF is a gelatinous material that can be produced as 
mechanically stable membranes, as reported by Kemmochi et al., who found that PRF 
promoted meniscal healing in a clinical trial44. Remarkably, PRF is the only autologous blood-
derived material that is a source of GFs (e.g. PDGF-BB, TGF-β1, IGF-1) and that has, at the 
same time, scaffolding properties. Moreover, PRF releases GFs in a more sustained way (up 
to 10 days) than PRP45.  
 
3.2.1.2. Scaffolds based on other natural polymers  
Apart from the ECM-derived macromolecules, other natural polymers, such as chitosan (CS) 
and silk fibroin, have been employed for GF delivery in meniscus TE (Table 2). CS is a 
biodegradable and positively charged polymer with mucoadhesive, hemostatic and 
antimicrobial activity46. The group of Buschmann described chitosan freeze-dried implants for 
the sustained release of PRP47, 48. The implants promoted platelet activation, granule 
secretion, and a sustained release of epidermal growth factor (EGF) over a 7 day period48. In 
vivo assays after subcutaneous implantation of CS/PRP scaffolds in rabbits revealed the 
capability of these implants to persist for at least 6 weeks in situ and to evoke cell migration, 
as well as the formation of a collagen-rich tissue48. Positive outcomes in terms of scaffold 
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integration and tissue healing were also observed in an ovine model after orthotopic 
implantation47.  
 Silk fibroin is an attractive biomaterial due to its biocompatibility, mechanical and 
degradative properties. Silk fibroin sponges have been loaded with platelet-rich gel (PRG), a 
PRP-derived gel, and supported a sustained release of TGF-β1 over a 20 day period49. 
Orthotopic implantation of the sponges in a total meniscectomy model revealed cell infiltration, 
tissue matrix synthesis and reduction of cartilage degeneration at 3 months.     
 
3.2.1.3. Scaffolds based on polyesters 
Due to their biodegradability and biocompatibility, synthetic polyesters have been widely used 
to prepare 3D porous constructs in TE. Scaffolds made of polyesters generally offer 
reproducibility, versatility and adequate mechanical properties29. Moreover, the most 
commonly used polyesters have a thermoplastic behavior, which enables their processing via 
3D printing50, 51. However, the main limitation of synthetic polyesters for TE application is their 
lack of domains that can be recognized by cells, and therefore, unlike most of the natural 
polymers, they have poor cell-instructive properties52.  
PLGA-based scaffolds offer the possibility to tune their hydrolytic degradation profile 
and the release kinetics of the entrapped proteins by varying the polymer characteristics (e.g. 
molecular weight, lactide/glycolide ratio), as well as the morphological properties of the system 
(e.g. porosity, scaffold density)53, 54. In fibrocartilage TE, PLGA scaffolds have been used to 
deliver PRP-derived GFs55. Kwak et al. demonstrated that PRP adsorbed onto PLGA meshes 
favored cell attachment of human articular chondrocytes and supported meniscal healing in a 
subcutaneous murine model55 (Table 3). Other studies described scaffolds fabricated by 
ethanol-sintering PLGA microspheres, previously loaded with TGF-β1 and BMP-256, 57. 
Unfortunately, the percentage of GF released was lower than 20%, suggesting its inactivation 
within the polymer matrix. This could be attributed to the well-known phenomenon of protein 
inactivation during the polymer degradation process53.  
15 
 
Polycaprolactone (PCL) has a slow degradation rate (from months to years), excellent 
mechanical properties and an easy-to-handle thermoplastic behavior58. In fact, 3D printing of 
PCL has been used to fabricate scaffolds that host GF-releasing microparticles for meniscus 
and TMJ disc regeneration25, 59, 60, as further described in section 5.1.  
 
3.2.1.4. Scaffolds based on hybrid materials 
The success achieved by combining multiple components is underlined by the fact that the 
two meniscal implants available in the clinics, i.e. CMI® and Actifit®, are indeed hybrid 
materials. Collagen Meniscus Implant (CMI®, Ivy Sports Medicine, Germany), commercialized 
in Europe since 2016, is based on purified bovine collagen I and glycosaminoglycans; whereas 
Actifit® (Orteq Ltd., UK) contains polycaprolactone and polyurethane61-63. Moreover, 
NUsurface® (Active Implants Israel Ltd., Israel), made of polyethylene and polycarbonate-
urethane, is in the process of FDA approval for total meniscus replacement61. Although none 
of these scaffolds has been loaded with GFs, several GF-loaded hybrid scaffolds are currently 
under investigation.  
 Hybrid scaffolds for meniscal GF delivery have been made by combining different 
natural polymers, or natural and synthetic polymers (Table 4). The combination of cell-binding 
macromolecules (e.g. collagen) with highly charged natural polymers (e.g. negatively charged 
polysaccharides), which support electrostatic interactions with GFs, has been investigated. 
For example, scaffolds based on collagen and chondroitin sulfate have been designed for the 
sustained release (up to 21 days) of PRP GFs (IGF-1, PDGF-AB and TGF-β1)64. Moreover, 
Matrigel, a gelatinous mixture of proteins secreted by Engelbreth-Holm-Swarm mouse 
sarcoma cells, has been mixed with hyaluronic acid for the delivery of VEGF65. Furthermore, 
scaffolds based on bovine meniscus-derived decellularized matrix have been chemically 
functionalized with heparin to efficiently entrap PDGF-BB66. In the latter study, the sustained 
release of PDGF-BB over the course of two weeks promoted cell migration and scaffold 
integration within the avascular meniscus, in an in vitro bovine meniscus organ culture.  
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 Another trend is the use of hydrogels based on chemically cross-linked natural 
derivatives and synthetic polymers. This strategy exploits the biocompatibility and bioactive 
properties of natural polymers, the reproducibility, versatility and non-immunogenicity of 
synthetic polymers, and the mechanical stability given by the chemical cross-linking. In these 
systems, polyethylene glycol seems to be the synthetic polymer most commonly used. For 
example, a system composed of thiol-modified hyaluronic acid (HA-SH) crosslinked with 
polyethylene glycol diacrylate (PEG-DA) was used to load PDGF-BB67. An in vivo study 
performed in rabbits concluded that this system decreased disc degeneration and cell 
apoptosis68. Details about PDGF-BB release kinetics from HA-SH/PEG-DA hydrogels, absent 
in this study, can be found in the work of Peattie et al.69. In this article, a first-order release 
kinetics was observed for all GFs in the study (VEGF, bFGF, TGF-β, keratinocyte GF (KGF), 
Angiopoietin-1 (Ang1), PDGF). Moreover, thermosensitive, injectable hydrogels based on 
glycol CS and multialdehyde-functionalized PEG have been loaded with TGF-β1, and 
supported fibrochondrogenic differentiation of bone mesenchymal stromal cells in vitro and 
fibrocartilaginous tissue growth in vivo70. 
           
3.2.1.5. Microparticle-loaded scaffolds 
Aiming at the regeneration of small defects, injectable microparticles have also been proposed 
to deliver in situ GFs for meniscus regeneration. To reduce the clearance of the microparticles 
at the injection site and to further modulate GF release, microparticles are often loaded into 
hydrogels71. For example, PLGA particles embedded into fibrin hydrogels have been 
investigated for GF delivery into meniscal tears. A sequential release of CTGF and TGF-β3 
was achieved by entrapping CTGF, as such, in the fibrin gel and TGF-β3 in the polymeric 
particles72, 73. This differentiated delivery of GFs supported the healing of avascular meniscal 
tears in an in vitro bovine explant model and in an in vivo leporine model.  
 GF-loaded PLGA particles have been also included in more sophisticated 3D printed 




3.2.2. Film-coated suturing wires 
Another possibility for the local delivery of GFs is to impregnate the wires used in meniscus 
surgery with these bioactive molecules. For example, poly-(lactic acid) (PLA)-coated suturing 
wires has been reported for the local administration of pro-angiogenic vascular endothelial 
growth factor (VEGF) (Table 5)15, 74. Petersen et al. investigated the potential of this approach 
to promote healing of meniscal tears in the avascular zone, where the poor spontaneous 
healing is often attributed to its lack of vascularization15. Results show that VEGF/PLA-coated 
sutures induced accumulation of endothelial cells in the tissue, but did not promote 
vascularization nor meniscal healing in an ovine in vivo model15. Similar outcomes were 
reported by Kopf et al. using (PLA)-coated suturing wires in a similar in vivo setting74. Lack of 
vascularization may be explained by the low amount of VEGF used and/or by its fast release 
kinetics, mainly governed by a pore diffusion-based mechanism74, 75. Moreover, it has been 
reported that local administration of VEGF up-regulates degradative enzymes, i.e. 
metalloproteinases (MMPs), and reduces the levels of MMPs-inhibitors, which in turn may 
hamper the VEGF-mediated tissue regeneration15, 74. Early work using suture coatings based 
on glutaraldehyde-crosslinked gelatin for sealing meniscal tears has also been reported. For 
example, a positive effect on meniscal cell proliferation was observed when FGF-2 was 
delivered using this strategy in an in vitro organ culture76.  
To sum up this section, scaffolds have been the GF delivery system for meniscal 
regeneration most frequently used. The most promising scaffolds are hydrogels based on 
ECM derivatives (e.g. collagen and gelatin) because they offer a biomimetic microenvironment 
that supports cell infiltration and differentiation, and their mechanical properties can be 
improved thanks to specific cross-linking reactions. On the other hand, scaffolds based on 
polyesters, despite providing adequate mechanical properties, have been scarcely employed 
so far. This is likely due to their poor cell-material interactions and the possibility of GF 
inactivation during polymer hydrolytic degradation. Another path also receiving a lot of 
attention is the development of hybrid scaffolds that aim at synergizing the advantages of two 
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or more materials. Finally, the use of microparticle-loaded scaffolds, hardly explored so far, 
represents a promising strategy that combines the benefits of the scaffolding material with the 
flexibility that microparticles offer in terms of GFs controlled delivery.  
It is important to note that the aim of the majority of the reported studies is to deliver 
GFs in order to heal meniscal tears and other small fibrocartilaginous defects. For this reason, 
the described biomaterials are mainly designed as DD systems (as opposed to TE constructs), 
and limited emphasis is given to the scaffold architectural and mechanical requirements. On 
the contrary, when aiming at a biofunctional meniscus regeneration, especially after total or 
subtotal meniscectomy, scaffold requirements are much more demanding and they have to 
take into account the complexity of the native tissue (regionally-variant biochemical and 
cellular composition) and the mechanically challenging location. To this purpose, advanced 
manufacturing technologies and synergies between these technologies and DD strategies are 
being explored, as discussed in the following sections. 
   
4. Recent advances in meniscal zonal reconstruction 
The intensive research on meniscus anisotropy of the last decades has boosted technological 
approaches that exploit this knowledge to develop novel therapeutic solutions77. In this 
context, modern techniques capable of designing scaffolds at the micro- and nanoscale are 
expected to make a huge impact in the field. This is the case of 3D fabrication technologies, 
such as 3D (bio)printing and electrospinning, that can generate zone-dependent structural 
features. 3D printing is based on the layer-by-layer deposition of a biomaterial and allows a 
precise construct shaping in terms of overall morphology and internal structure. This means 
that 3D printed TE constructs not only can fit the size and the shape of the tissue defect 
precisely, but can also reproduce zonal variations of the native tissue78-81. 
3D fabrication technologies for zonal fibrocartilage TE currently under investigation rely 
on (i) mimicry of the arrangement of collagen fibers and bundles25, 59, 60, 82-90, (ii) zone-
dependent biomaterial composition91-93 and (iii) different degree of porosity91, 92, 94.  
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Besides these manufacturing technologies, the mechanical stimulation of pre-
formed, cell-seeded TE constructs in bioreactors is another strategy to obtain zonal 
fibrocartilage differentiation89, 93, 95-97. Modern bioreactors can produce mechanical loads in 
compression and tension that mimic the mechanically challenging environment of the articular 
joint. A zone-dependent mechanical stimulation, such as the one acting on the meniscus 
(tension-dominating in the outer zone and compression-dominating in the inner zone), can 
result in zonal cellular and tissue differentiation97.  
Furthermore, the region-specific use of different cell types has also been explored 
for zonal tissue regeneration. Different cell types are responsible for the synthesis of different 
ECM components and therefore of different types of tissue.  
On the next section, we discuss relevant studies in which zonal meniscal 
reconstruction has been attempted by means of manufacturing technologies, mechanical 
stimulation, and cell seeding techniques.               
 
4.1. Manufacturing technologies for zonally-variant meniscus 
4.1.1. Conventional technologies for controlling porosity 
Since the very beginning of the TE era, researchers realized that porosity was one of the key 
parameters that could determine the success of a scaffold. Indeed, porosity and 
permeability of TE constructs promote cell infiltration, tissue ingrowth, and transport of the 
nutrients and waste products generated during cellular metabolism. A typical porosity higher 
than 90% is often considered optimal, together with a pore size ranging between 10 and a few 
hundred micrometers, as a function of the targeted tissue. Moreover, interconnectivity 
between pores to form microchannels, is also a desirable feature of a TE scaffold98.  
Some of the most commonly used methods to prepare porous scaffolds from polymers 
include: (i) solvent casting/particle leaching, which relies on leaching out solid particles from 
the polymer solution; (ii) gas foaming, which involves the formation of gas bubbles within the 
melted polymer; (iii) thermally-induced phase-separation, based on a liquid-liquid phase 
separation of the polymer solution at temperatures lower than the freezing point of the solvent; 
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(iv) melt molding, which relies on the compression of the polymeric material and porogens at 
temperatures higher than the polymer glass transition temperature; and (v) cryostructuring 
procedures, such as cryotropic gelation and freeze-drying98, 99.  
Porosity can be controlled by properly adjusting the fabrication parameters. For 
example, in a study by Sarem et al., anatomically shaped multi-layered meniscal scaffolds 
made of crosslinked gelatin and CS were fabricated via the multi-step freeze-drying method 
(Table 6)91. Pore size, total porosity, as well as compressive and tensile moduli could be tuned 
over a broad range of values by varying the gelatin/CS ratio. Selected compositions were then 
used to develop laminated gradient scaffolds able to mimic the anisotropy of native 
meniscus91.  
Other studies highlighted that the pore organization (i.e. random vs ordered) plays a 
crucial role on the quality of the newly formed tissue and its remodeling92, 94. Formation of 
aligned micropores within meniscal scaffolds via cryostructuring has been reported by 
Stuckensen et al.92. In this study, the mimicry of inner and outer meniscus was achieved by 
controlling the porosity (through a zone-dependent pore size and pore alignment), and by 
using a zone-dependent hydrogel composition (different percentages of collagen type I, II, and 
chondroitin sulfate). In line with these findings, a beneficial effect of an ordered pore 
distribution in meniscal scaffolds was found in vivo in a subcutaneous model by de Mulder et 
al.94. Scaffolds made of PCL-PLA-polyurethane block-copolymer with different micro-pore 
organization (i.e. random vs channel-like), supported different assembly of the ingrown tissue.  
No consensus has been established yet on what would be the ideal pore/channel 
diameter in an artificial meniscus. A study reported that the optimal pore size range for 
meniscal tissue ingrowth in vivo was between 150 and 500 µm100. Nevertheless, based on 
more recent studies, a broader range (20-550 µm) is currently being investigated for studying 
cell invasion and meniscal tissue ingrowth. In fact, a channel diameter ˂150 µm would be in 
line with that of collagen bundles in human meniscus (i.e. 88 µm)94. In general, porosity 
facilitates cell infiltration, mass influx/efflux, and tissue ingrowth, but the presence of big pores 
reduces the scaffold mechanical properties, which are crucial for the mechanically demanding 
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environment of the knee joint. The choice on pore size for meniscal scaffolds is currently a 
trade-off between different contrasting aspects, and future investigations may shed light upon 
this matter101. 
Apart from controlling the porosity of the scaffolds prepared by conventional methods, 
nowadays engineers count on technologies, such as 3D printing and electrospinning, that, not 
only offer the possibility of tuning the porosity, but also allow for a more accurate mimicry of 
the meniscus heterogeneous ultrastructure. In the next sections, we discuss relevant studies 
that use these technologies for meniscal TE. 
 
4.1.2. 3D printing of zonally-variant meniscus 
Meniscal scaffolds with controlled micro-architecture can be obtained by 3D printing. PCL is 
the most frequently used biomaterial because it can be easily processed by this method, and 
displays adequate mechanical properties102. Size and shape of the internal channels and 
mechanical properties of the scaffold can be modified by changing 3D printing parameters, 
such as fiber spacing, offset between layers, and fiber orientation (Table 7)82. Fiber spacing 
also affects the morphology of recruited cells and the organization of newly-deposited 
collagen. For example, according to Warren et al. the alignment of collagen in vivo (in an 
ectopic murine model) increased when they decreased the fiber spacing, probably because 
cell-scaffold interaction is facilitated in more narrow channels, and this better instructs the 
collagen deposition83.  
 More importantly, grafts engineered by 3D printing can replicate the 
circumferential/radial collagen arrangement of native meniscus, and this can result in 
anisotropic mechanical properties, similar to those of the meniscus60, 84, 85. For example, 
scaffolds based on circumferentially/radially aligned multiwalled carbon nanotubes (CNT) 
were able to approximate circumferential, radial, and compressive moduli of native meniscus 
(120, 48 and 0.69 MPa, respectively)84.  
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3D printing also allows scaffold fabrication based on two or multiple components. 
Therefore, meniscal constructs with a regionally-variant material composition can be 
fabricated. For example, in hydrogels based on reinforced alginate/acrylamide, region-specific 
compositions (different ratios between hydrogel and reinforcement) were used to obtain 
anisotropic mechanical properties85. Another possibility is to use dual 3D printing based on a 
thermoplastic material (e.g. PCL) and a hydrogel component, benefiting from the mechanical 
resistance of the former and the cell-friendly environment of the latter. To this purpose, 
constructs can be fabricated by the deposition of adjacent filaments of PCL alternating with 
cell-laden hydrogel103. Alternatively, pre-fabricated 3D printed constructs can be infused with 
cell-laden hydrogels. For example, Bahcecioglu et al. fabricated a 3D printed, anatomically-
shaped meniscus implant and subsequently infused it with two different cell-laden hydrogels 
in the inner and outer part, to mimic the bizonal biochemical composition of meniscal ECM90, 
93.  
3D printed scaffolds resembling collagen bundle organization of meniscus and other 
fibrocartilaginous structures have been also combined with spatio-temporal GF delivery25, 59, 
60, as further discussed in section 5.1.   
Overall, the reported studies highlight the great potential of 3D printing technology to 
mimic the collagen bundles arrangement in fibrocartilage implants. A critical difference among 
the reported studies lies on the structural organization of the fibers. While some studies 
employed a 0/90° interlaying fiber orientation83, 86, 93, others focused on a circumferential/radial 
fiber arrangement25, 59, 60, 82, 84, 85, 89, 90. Although the former approach can sufficiently mimic 
collagen bundle distribution of native fibrocartilage on a millimeter-size scale, it does not take 
into account the overall variation of fiber orientation on a bigger scale (Figure 2). In fact, for 
example, a change in fiber direction of ~160-200° over ~7-10 cm has been reported for the 
human meniscus, which results in circumferential fibers that run along the C-shaped meniscus 
structure87. For this reason, when aiming at the reconstruction of large meniscal defects or the 
whole meniscus, a circumferential/radial fiber organization that better mimics the macroscopic 




4.1.3. Electrospinning for zonally-variant meniscus 
One of the main limitations of traditional 3D printing is that it does not allow the manufacturing 
of nano-scale fibers, like the ones present in tissue ECM104 (Figure 3). As an alternative, the 
fabrication of nanofibers via electrospinning has attracted much interest105, 106. For example, 
Han et al. designed TE constructs made of aligned electrospun PCL nano-fibers, embedded 
with mesenchymal stem cells (MSCs) and meniscal fibrochondrocytes (Table 8)107. In vitro 
studies showed the formation of a heterogeneous neo-tissue with collagen type I and II zone-
dependent deposition.  
As mentioned in the previous section for 3D printed scaffolds, the orientation of the 
generated fibers is currently an important subject of study. For example, PLA nanofibrous 
scaffolds based on aligned fibers have a much higher tensile modulus compared to scaffolds 
based on randomly distributed fibers108. Moreover, the comparison of scaffolds made of PCL 
electrospun fibers with different orientation (0°, 90° or circumferential) revealed that, the 
direction of newly formed collagen and mechanical properties of the scaffolds were 
significantly affected by this parameter88. Remarkably, in scaffolds made of electrospun PCL 
nanofibers, circumferential alignment elicited regionally-variant mechanical properties that 
cannot be obtained with linearly aligned nanofibrous scaffolds87.  
Taken altogether, since bio-functional meniscal implants are likely to be achieved 
using a design that mimics the native tissue at nano-, micro- and macroscopic scales, cutting-
edge technologies involving the combined use of electrospinning and 3D printing may 
represent a valid and novel strategy104, 109.     
To sum up this section, traditional porogenic technologies, 3D printing and 
electrospinning are currently being investigated with the aim to engineer zonally-variant 
meniscus. Although conventional porogenic technologies allow for the tuning of the total 
porosity, pore size and pore organization, 3D printing and electrospinning offer higher 
versatility in terms of macro-, micro- and nano-structuring. Overall, 3D printing is the most 
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used technique because it allows the modification of the channel size and shape by changing 
certain fabrication parameters (e.g. fiber spacing, layer offset, etc.), and this has a direct effect 
on the scaffold mechanical properties, cell morphology and organization of newly-formed 
collagen. Moreover, 3D printing of circumferential/radial fibers mimics the organization of 
collagen in native meniscus, and can result in anisotropic mechanical properties and zonally-
variant tissue regeneration. Furthermore, 3D printing allows the fabrication of multi-component 
(e.g. gel and reinforcing material) scaffolds, which integrate a cell-friendly environment into a 
mechanically-resistant structure. Finally, 3D printing offers the highest versatility in terms of 
macroscopic scaffold shaping, which is crucial for customized therapies. Of all the materials 
currently employed, PCL is the most used in the 3D printing of meniscus scaffolds. The major 
disadvantage of 3D printing is the difficulty to fabricate nano-sized fibers, which would mimic 
better the endogenous collagen fibers. In this sense, electrospinning is the most suitable 
alternative. So far, the research on electrospun meniscal scaffolds is still limited, likely due to 
challenges in fabricating large scaffolds and controlling fiber orientation. Nevertheless, current 
research has demonstrated that linearly and circumferentially alignment can be achieved, 
which has a direct impact on the scaffold mechanical properties. 3D printing and 
electrospinning have been also used to fabricate protein-releasing meniscus scaffolds, that 
integrate a DD strategy into structurally-organized scaffolds (discussed in section 5).  
   
4.2. Mechanical stimulation of pre-formed cell-seeded scaffolds for the fabrication of 
zonally-variant meniscus 
Mechanical stimulation of pre-formed cell-seeded cartilage constructs in bioreactors, referred 
to as dynamic culture, is being currently under investigation with the aim to promote cell 
differentiation and maturation of neo-tissues in vitro110-113. In fact, cells respond to mechanical 
stimuli with morphological changes and production of specific signaling molecules114. Several 
studies have shown the superiority of the dynamic culture of fibrocartilage scaffolds over 
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traditional static culture, in terms of internal organization and mechanical properties of the 
newly formed tissue93, 95-97, 114 (Table 9).  
The methods to induce mechanical stimulation on meniscal implants rely on a bi-axial 
dynamic loading intended to simulate the compressive (generated by squeezing forces) and 
tensile (generated by stretching forces) stress generated in the joint during the movement. A 
mimicry of the complexity of meniscal mechanics has been obtained by gradually increasing 
both tensile and compressive stress forces from the outer to the inner zone, or by applying a 
tensile-dominating stimulation in the outer zone and a compressive-dominating stimulation in 
the inner zone89, 93, 97. The application of zonally variant stress forces was found beneficial for 
the zone-specific deposition of meniscal ECM components and the induction of cell 
differentiation93, 97. For example, in the study of Bahcecioglu et al., anatomically shaped 3D 
printed PCL scaffolds were impregnated with porcine fibrochondrocytes-laden agarose and 
gelatin hydrogels in the inner and the outer zone, respectively. The combination of zonally-
variant mechanical stimulation and material composition resulted in the formation of a neo-
tissue with zone-specific collagen type and GAG deposition, which resembles the biochemical 
composition of meniscal ECM93. Promising results were also reported in the study of Puetzer 
et al., where dual compressive-tensile mechanical stimulation of collagen gels loaded with 
bovine meniscal fibrochondrocytes promoted a high degree of collagen organization, a zone-
dependent cell morphology and anisotropic mechanical properties97. Moreover, in the outer 
zone, the tensile-dominating stimulation favored a predominant collagen production, whereas 
in the inner zone, the compressive-dominating stimulation triggered a higher GAG production 
as observed in native meniscus.  
Another way to promote native tissue organization in meniscal implants takes 
advantage of the mechanical clamping of the scaffolds at the horns, in order to mimic the 
physiological meniscal attachments to the tibia. To be able to use this approach, scaffolds with 
extensions at the horns have to be produced to allow the anchoring, as described by Puetzer 
et al.115. In this study, anatomically shaped collagen scaffolds loaded with fibrochondrocytes 
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and clamped at the horns, supported a circumferential/radial collagen organization and 
developed anisotropic mechanical properties.       
Despite all the positive outcomes described above, matching the tensile mechanical 
properties of the native meniscus using mechanical stimulation remains an unmet challenge. 
Indeed, while the compressive moduli of these scaffolds are comparable, or even higher, than 
that of the human meniscus, the tensile moduli are significantly inferior93, 97, 115. This points out 
the importance in meniscal TE of aiming not only at a sufficient amount of deposited collagen, 
but also at a high level of its fiber organization into bundles, which is directly correlated with 
the tensile resistance.  
The combined effect of mechanical and chemical stimulation on fibrocartilage scaffolds 
has been also investigated89, 95, 96, 114. In some of these studies, mechanical stimulation via 
rotary cell culture systems was combined with the use of TGF-β3 in the culture medium. Rotary 
cell culture systems are bioreactors in which the rotation of the vessel, where the construct is 
cultured, generates a dynamic laminar flow that promotes a better mass transport throughout 
the scaffold. Using this strategy, Marsano et al. engineered cell-seeded, hyaluronate-based 
scaffolds with a bi-zonal organization95, 96. The outer region of the scaffolds presented high 
content of collagen type I and contained elongated cells, whereas the inner region was richer 
in GAG, collagen type I and II, which resembles the composition of the native meniscus95, 96. 
Moreover, this zone-dependent composition had a direct impact on the mechanical properties 
of the scaffolds. Indeed, the outer region presented higher elastic modulus in tension as 
expected for a collagen-rich tissue, while the inner region displayed higher elastic modulus in 
compression as expected for a GAG-rich tissue. The synergistic effect of the mechanical and 
chemical stimulation has been also reported by Zhang et al.89, who developed cell-seeded 3D 
printed meniscal scaffolds supporting zonally-variant matrix deposition in vitro and in vivo.    
 
4.3. Cell type-dependent strategies for the fabrication of zonally-variant meniscus 
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Differences in the cell types present in the native meniscus play a pivotal role for the zonally-
variant histological, biochemical, and mechanical profile of this tissue. The presence of 
fibroblast-like cells in the outer zone and chondrocyte-like cells in the inner zone of the 
meniscus is responsible for forming a more fibrocartilaginous tissue in the former and a more 
cartilaginous one in the latter. As a consequence, the outer zone is stiffer in tension and the 
inner zone in compression.  
TE approaches aiming at reproducing the anisotropic meniscal architecture by using 
spatially-distributed different cell types have been reported (Table 10). A bio-inspired strategy 
in this respect is the use of meniscal cell sub-populations isolated from the outer and inner 
region, as described by Baek et al.108. In this study, human meniscal cells isolated from the 
vascular and avascular regions were seeded on PLA scaffolds made of electrospun fibers. 
Nevertheless, no significant differences in gene expression of relevant markers were seen 
between the two cell groups, likely because a fibroblast-like cellular phenotype persisted in 
both.  
Conversely, the use of a different cell type combination involving articular 
chondrocytes and fibroblasts seems to be more promising. Mandal et al. reported the 
fabrication of silk scaffolds seeded with chondrocytes in the inner zone and human fibroblasts 
in the outer zone116. Results showed that chondrocytes maintained their native phenotype and 
were responsible for a high GAG, collagen type I and II production, which is desirable for the 
inner meniscal zone. In contrast, fibroblasts synthesized much less GAG, did not synthesize 
collagen type II, and supported the deposition of collagen type I, which mirrors the ECM 
composition of the outer meniscal zone.  
As described by Higashioka et al., a similar biomimetic tissue composition, in which 
GAG is more abundant in the inner zone and collagen in the outer zone, has been achieved 
also by seeding chondrocytes in the inner zone and a mixture of chondrocytes and meniscal 
cells in the outer zone in an in vitro scaffold-free approach117. Remarkably, in this study the 
differences in the biochemical composition of the two different regions had a direct impact on 
the mechanical properties of the newly formed tissues. Indeed, the inner zone displayed a 
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much higher compressive modulus compared to the outer zone, which was stiffer in 
(circumferential) tension.  
The scarcity of studies performed employing spatially-variant cell seeding strategies in 
the field of meniscal TE indicates the complexity of the procedure, which involves several 
steps and challenges (isolation of different cell types, identification of the best cell cocktail for 
each zone, selective spatial localization of the cells, etc.). Nevertheless, when considered from 
another point of view, it might reflect the novelty of this approach and, from a more general 
perspective, it indicates that aiming at an anisotropic reconstruction of meniscus is still a 
cutting-edge research line.             
 
5. Synergies between DD and TE technologies 
Given the complex and anisotropic nature of the meniscus, novel approaches combine DD 
technologies for the controlled release of one or multiple GFs, with TE strategies that aim at 
resembling the native micro- and nanoarchitecture. In these biomaterials, the combination of 
a biochemical stimulation (via e.g. GFs) provided in a temporarily and/or spatially-controlled 
manner, together with the biomimicry of structural features may lead to a synergistic effect on 
zonal tissue differentiation.        
 
5.1. Microparticle-loaded 3D printed scaffolds  
Novel systems combine the mechanical and biomimetic properties of 3D printed scaffolds with 
the flexibility that microparticles offer in terms of GF encapsulation and controlled release. 3D 
printed scaffolds having fiber architecture resembling that of collagen bundles can be loaded 
with microparticles for the release of one or multiple GFs. In this context, particle properties 
can be tuned to have a sequential release of different GFs (temporal control), and a spatially-
differentiated distribution of the particles can provide a zonal GF supply (spatial control). Using 
this approach, Lee and co-workers developed a meniscal implant with a spatio-temporal 
delivery of two different GFs, i.e. CTGF and TGF-β3, loaded into PLGA microparticles25. A 
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sequential and spatially-controlled release of the two GFs (faster CTGF release/outer zone 
and slower TGF-β3 release/inner zone obtained by using a different lactide/glycolide ratio), 
achieved over the course of 42 days, induced a zone-dependent collagen deposition in vitro 
(collagen type I in the outer zone and collagen type II in the inner zone) by human synovium 
mesenchymal stem/progenitor cells25. Moreover, zone-dependent fibrocartilaginous matrix 
deposition and mechanical properties were observed in vivo in an ovine model25.  
A similar system was used for TMJD regeneration, and in vitro and in vivo experiments 
confirmed a spatially-specific tissue regeneration that resembled that of native TMJD 
fibrocartilage59, 60. For such multi-component scaffolds, PLGA particles are a versatile tool that 
offers the possibility to control the release kinetics by adjusting the lactide/glycolide ratio and 
the molecular weight. These particles can be either infused within the channels of the 3D 
printed scaffold post-fabrication25, or mixed in the PCL melt and subsequently printed59, 60. 
Alternatively, the particles can be embedded into a hydrogel that is 3D printed between 
adjacent PCL filaments103. In this case, the hydrogel can be also used as a cell carrier103. In 
the described 3D printed scaffolds, the native collagen organization of fibrocartilage is 
mimicked by printing adequate 3D patterns of mechanically resistant PCL (or particle-loaded 
PCL) fibers25, 59, 60. Such systems are promising for large fibrocartilaginous defects (e.g. in 
subtotal and total meniscectomy models) where anatomically-shaped scaffolds with specific 
internal organization are especially needed.  
 
5.2. Protein-releasing nanofibrous scaffolds 
Aligned ultrafine fibers produced via electrospinning may mimic the organization of native 
collagen and provide, at the same time, a tool to deliver active factors. For this double purpose, 
nanofibrous hybrid scaffolds for meniscal TE have been fabricated (i) by mixing fibers made 
of different materials27, 118, (ii) by generating fibers from polymeric blends119, or (iii) by 
producing core-shell nanofibers120 (table 11).  
Using different materials can help provide valid scaffolding properties and allow to tune 
the release kinetics of different active factors. For example, Mauck et al. reported nanofibrous 
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scaffolds composed of PCL fibers, mixed with collagenase-releasing poly-(ethylene oxide) 
(PEO) fibers, and PDGF-AB-releasing HA fibers27, 118. In this three-component nanofibrous 
scaffold, mechanical support was provided by resistant PCL fibers, and a sequential release 
of collagenase and PDGF-AB was promoted by fast-dissolving PEO and crosslinked-HA 
fibers, with different degradation profiles27 (Figure 4). According to this study, a burst release 
of collagenase (80% in 5 h) is necessary to attain a localized matrix degradation of the tissue 
surrounding the defect to favor cell mobility and migration10, which is further enhanced by the 
subsequent release of chemotactic PDGF-AB (over 5 weeks). Importantly, in vivo studies in a 
murine xenotransplant subcutaneous model showed that PEO/HA/PCL nanofibrous scaffolds 
elicited localized collagen degradation, cell migration-mediated tissue repair, deposition of 
new collagen type I and II, and scaffold integration27. 
A main concern regarding electrospun fibers for protein delivery is the potential 
damage to the protein caused by the high voltage applied during the fiber production121. To 
avoid this, hybrid materials containing stabilizers can be fabricated to protect the entrapped 
proteins. For example, in some studies on meniscal GF delivery, bovine serum albumin (BSA) 
has been included among the fiber components119, 120. Interestingly, Qu et al. found a dose-
dependent protective effect of BSA on entrapped TGF-β3. For electrospun fibers, protein 
release kinetics generally consists on an initial burst release due to desorption of the GF from 
the fiber surface, followed by a sustained release due to polymer degradation119.  
The majority of the studies in the literature reported a predominant parallel alignment 
of the electrospun fibers, which could mimic the collagen arrangement for small tissue 
defects118-120. Nevertheless, achieving a highly defined circumferential/radial arrangement in 
anatomically-shaped scaffolds remains an unmet challenge for this technique. 
 
6. Conclusions 
DD and TE strategies are currently being investigated for the regeneration of human 
meniscus. DD focuses on the development of controlled release delivery systems for GFs, 
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which are key-players in cell recruitment and proliferation, extracellular matrix synthesis, and 
tissue remodeling. A large array of active factors (GFs and enzymes), mainly formulated into 
scaffolds, has been investigated. Nevertheless, the identification of the most suitable GF 
cocktail, GF ideal doses and release kinetics, as well as the determination of the most 
appropriate biomaterial(s) remain unmet challenges. On the other hand, recent advances in 
meniscal TE focus on the development of zonally-organized tissue constructs that attempt to 
mimic the anisotropic ultrastructure of the human meniscus. To this end, modern 
manufacturing technologies (e.g. 3D printing, electrospinning), dynamic cell culture 
techniques, and spatially-selective cell seeding have been explored with a certain degree of 
success. It is our understanding that these two strategies must be combined with the use of 
modern DD systems embedded in zonal TE constructs. This synergy has recently attracted 
much interest and may represent a key-point towards the achievement of a definitive 
breakthrough in this field. A scaffold with zonal GF supplementation, microarchitecture and/or 
cell disposition could have more chances of regenerating a fully active meniscus. Future work 
will clarify the suitability of this strategy taking also into account its bench-to-bedside 
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Figure 1. Schematic representation of human meniscus (horizontal cross-section, top, and 
vertical cross-section, bottom) highlighting zonal variations in vascularization, cell type 
localization, collagen type I and II distribution, and collagen fiber arrangement. 
 
Figure 2. Graphical representation of collagen orientation in native meniscus (horizontal 
cross-section). Macroscopic circumferential/radial arrangement (left) and perpendicular 
arrangement at a much smaller scale (right).    
 
Figure 3. Schematic representation of the use of 3D printing and electrospinning to engineer 
anisotropic meniscus constructs. 3D (bio)printing allows deposition of micro-sized, 
circumferentially/radially organized fibers, where a bi-zonal organization can be achieved by 
a spatially-selective deposition of different components (e.g. hydrogels, GFs-loaded particles 
and cells) (left). Electrospinning allows deposition of less ordered, but much thinner fibers that 
can mimic collagen in native meniscus (right). 
 
Figure 4. Stimulation of meniscal cell migration and tissue repair via temporal delivery of 
collagenase and PDGF-AB. Initially, fast-dissolving PEO fibers trigger the release of matrix-
degrading collagenase. Localized tissue degradation at the tissue-scaffold interface allows 
cell mobility through a less dense tissue matrix. Chemotactic activity of PDGF-AB further 

























Table 1. ECM-derived scaffolds for the controlled delivery of GFs for fibrocartilage 
regeneration. (In all the studies, the meniscus is the targeted tissue, except for31, where the 
TMJ osteochondral tissue is the target). 
Biomaterial Growth factor(s) Model Outcome Ref. 
Collagen scaffold BMP-2 In vivo 
leporine 
orthotopic 
Partial tissue healing (dose-










In vitro  























PRP In vivo 







FGF-2 In vivo 
leporine 
orthotopic 
Improved meniscal cell 
density and tissue healing 
(proteoglycans) 
39 
Fibrin hydrogel CTGF In vivo 
leporine orthotopic 
Capillaries and ECM 
(Collagen I and II) formation 
43 









No difference between PRF 




ECM: extracellular matrix; GFs: growth factors; BMP-2: bone morphogenic protein 2; TMJ: 
temporomandibular joint; TGF-β3: transforming growth factor beta 3; PRP: platelet-rich 





Table 2. Scaffolds based on other natural polymers for the controlled delivery of active factors 
for meniscus regeneration.  
Biomaterial Growth factor source Model Outcome Ref. 




Scaffold integration  
47 
Silk fibroin sponge PRG In vivo 
leporine 
orthotopic 
Cell infiltration and 
matrix synthesis 
49 





Table 3. PLGA-based scaffolds for the delivery of growth factors in fibrocartilage regeneration.  
Targeted tissue Growth factor(s) Model Outcome Ref. 





Attachment of seeded 
articular chondrocytes and 













PLGA: poly-(lactic-co-glycolic acid); PRP: platelet-rich plasma; TGF-β1: Transforming growth 





Table 4. Scaffolds based on hybrid materials for the controlled delivery of growth factors for 
fibrocartilage regeneration. (In all the studies, meniscus is the targeted tissue, except for68, 
where the IVD is the targeted tissue).  
Biomaterial Growth 
factor(s) 
Model Outcome Ref. 
Fiber-reinforced 
collagen/chondroitin sulfate 





human meniscal cells 
Increased cell number; 









In vivo  
ovine 
orthotopic 




BMP-7 In vivo  
ovine 
orthotopic 






PDGF-BB In vitro  
bovine meniscus organ 
culture  





acid/ polyethylene glycol 
diacrylate hydrogel 





Inhibition of cell apoptosis 























IVD: intervertebral disc; EDC/NHS: 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide/N-
hydroxysuccinimide; PRP: platelet-rich plasma; VEGF: vascular endothelial growth factor; 
BMP-7: Bone morphogenic protein 7; PDGF-BB: platelet-derived growth factor BB; TGF-β1: 





Table 5. Film-coated suturing wires for the controlled delivery of growth factors for meniscus 
regeneration.  
Biomaterial Growth factor Model Outcome Ref. 
PLA suture coating VEGF In vivo 
ovine 
orthotopic 
Presence of endothelial cells;  
No angiogenesis; 
No meniscal healing 
15 












Proliferation of meniscal cells; 
Inhibition of meniscal death 
76 






Table 6. Studies aiming at mimicking zonally-variant meniscus architecture by controlling 
porosity. 




























Collagen I and 
II/chondroitin 




stromal cells and 
endothelial cells 



























Table 7. Studies aiming at mimicking zonally-variant architecture of meniscus by using 3D 
printing. 
Strategy Biomaterial Model Outcome Ref. 











offset)   
82 
Perpendicular fiber organization in 
scaffolds with varying strand spacing  






recruited cells and 
collagen alignment 
in newly formed 
matrix  
83 
Circumferential/radial fiber arrangement 
(combined with biochemical and 
biomechanical stimulation) 
















deposition and cell 
phenotypes  
89 
Perpendicular PCL strand orientation 
(combined with zone-dependent 
hydrogel composition and 










Protective effect of 


















deposition of ECM 
components 
90 




























Perpendicular strand organization Methacrylated 













tissue formation and 
scaffold integration 
86 





Table 8. Studies aiming at mimicking zonally-variant fibrocartilage architecture by using PCL-
based electrospinning. (In all the studies, meniscus is the targeted tissue, except for107, where 
fibrocartilage in general is the targeted tissue). 
Strategy Model Outcome Ref. 
Aligned fiber orientation;  
(combined with dual cell 
seeding)  
In vitro  
bovine mesenchymal stem cells 
and meniscus fibrochondrocytes 
Domain-dependent collagen matrix 
deposition, cellular nuclei morphology, 
mechanics and intracellular calcium 
signaling  
107 
Different fiber orientation 
in single-layer and multi-
layer scaffolds 
In vitro  
bovine mesenchymal stem cells 
Fiber orientation-dependent scaffold 
stiffness and direction of newly formed 
collagen; 
Fiber orientation-dependent collagen 
amount and cell infiltration; 
Positive mechanical reinforcement by 




In vitro  
bovine mesenchymal stem cells 









Table 9. Studies aiming at mimicking zonally-variant fibrocartilage architecture by using 
different mechanical stimulation technologies. (In all the studies, meniscus is the targeted 
tissue, except for114, where the TMJ disc is the targeted tissue).  











3D printed PCL 
scaffold 
impregnated with 
agarose (IZ) and 
methacrylated 







Protective effect of 


















































deposition and cell 
phenotypes  
89 
Mimicry of meniscal 
attachment at the 
tibia  
Mechanical 
anchoring at the 
horns 















bovine and human 
Bi-zonal engineered 






acid and insulin) 
rotary cell culture 
system 
hyaluronic acid  articular 
chondrocytes 
collagen distribution 





acid and insulin) 
Hydrodynamic flow 
using perfused 
rotary cell culture 






























TMJ: temporomandibular joint; 3D: three-dimensional; PCL: polycaprolactone; OZ: outer 
zone; IZ: inner zone; GAG: glycosaminoglycans; ECM: extracellular matrix; TGF-β: 




Table 10. Studies aiming at mimicking zonally-variant meniscal architecture by spatially-
selective seeding of different cell types. 
Strategy Biomaterial Model Outcome Ref. 
Different cell type 
seeding and use of 




fiber scaffold + 
hydrogel made of 
collagen II, 
chondroitin sulfate 
and hyaluronic acid 
In vitro 
human meniscal cells 
from vascular (OZ) 
and avascular zone 
(IZ) 
No significant differences in 
gene expression between 
cell types; 
Fiber orientation-dependent 
cell morphology and 
alignment  
108 
Different cell type 
seeding and use of 
material layers with 
different porosity 







Cell-type dependent GAG 











meniscal cells (OZ) 
bovine articular 
chondrocytes (IZ) 
Cell-type dependent GAG 
and collagen production; 
Cell-type dependent 
mechanical properties of 
formed matrix 
117 





Table 11. Scaffolds based on nanofibrous hybrid scaffolds for the controlled delivery of active 
factors for fibrocartilage reconstruction. (In all the studies, meniscus is the targeted tissue, 
except for119, where fibrocartilage in general is the targeted tissue). 
Biomaterial Enzyme/growth 
factor 










Increased tissue porosity and 
cell density; 
































PDGF-BB In vitro  
human meniscal and 
synovial cells 
Increased cell proliferation 






TGF-β3 In vitro  
bovine synovium-
derived stem cells 





PCL: polycaprolactone; PDGF-AB: platelet-derived growth factor AB; BSA: bovine serum 
albumin; PLA: poly-(lactic acid); PDGF-BB: platelet-derived growth factor BB; PLGA: poly-
(lactic-co-glycolic acid); TGF-β3: transforming growth factor beta 3. 
